Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
07/15/2008 | US7399758 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
07/15/2008 | US7399756 Organo-phosphorous compounds for activating gamma/delta T cells |
07/15/2008 | US7399605 Generating preferential polymerase in sample; obtain nucleotide sequences, incubate in reaction mixture, translate nucleotide sequences, recover polypeptide |
07/15/2008 | US7399477 Genome segment, vaccine; temperature sensitivity, dominant interference, or attenuation; therapeutics, to protect animals from diseases caused by influenza A viruses, and in particular, to protect horses from disease caused by equine influenza virus |
07/15/2008 | US7399473 Virus coat protein/receptor chimeras and method of use |
07/15/2008 | US7399472 Vaccines |
07/15/2008 | US7399464 Polypeptides of the IFNα-7 gene |
07/15/2008 | US7399463 HSA-free formulations of interferon-beta |
07/15/2008 | CA2480583C Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
07/15/2008 | CA2407606C Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents |
07/15/2008 | CA2378892C Preserved pharmaceutical formulations |
07/15/2008 | CA2250861C Cyclic adhesion inhibitors |
07/15/2008 | CA2250630C Novel lantibiotic related to actagardine, and processes for the preparation and use thereof |
07/15/2008 | CA2207103C Methods to identify hemochromatosis |
07/15/2008 | CA2205557C Monofunctional and/or polyfunctional polylysine conjugates |
07/15/2008 | CA2113023C Tnf receptor promoter |
07/10/2008 | WO2008082488A1 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
07/10/2008 | WO2008082484A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
07/10/2008 | WO2008082198A1 Antifungal triazole derivatives, method for the preparation thereof and pharmaceutical composition containing same |
07/10/2008 | WO2008082009A2 Fused substituted aminopyrrolidine derivative |
07/10/2008 | WO2008081940A1 Gel composition for treating mycosis |
07/10/2008 | WO2008081937A1 Protein toxin secretion inhibitor |
07/10/2008 | WO2008081901A1 Pharmaceutical alkyl gallate composition |
07/10/2008 | WO2008081608A1 Method of feeding mother pig |
07/10/2008 | WO2008081607A1 Method of preventing diseases in piglings in the weaning stage |
07/10/2008 | WO2008081266A1 Compounds for the treatment or prevention of infection by flaviviridae |
07/10/2008 | WO2008080965A2 Hiv inhibiting 5,6-substituted pyrimidines |
07/10/2008 | WO2008080964A1 Hiv inhibiting 6-substituted pyrimidines |
07/10/2008 | WO2008080408A1 Thioxanthene derivates usefulto treat infectious diseases |
07/10/2008 | WO2008080398A1 Anti - infective agents such as phenothiazine and thioxanthene derivates to treat infectious diseases |
07/10/2008 | WO2008080302A1 NEW SCHEME OF COMBINING CYTOKINE FUSION PROTEIN (IL-2/Fc) AND TRADITIONAL CHINESE MEDICINE COMPOUND 861 FOR ENHANCING IMMUNE RESPONSE OF HEPATITIS B VACCINE AND BREAKING IMMUNE TOLERANCE OF HEPATITIS B VIRUS |
07/10/2008 | WO2008064311A3 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties |
07/10/2008 | WO2008063982A3 High mannose glycoprotein epitopes |
07/10/2008 | WO2008063600A3 Triazolyl tropane derivatives |
07/10/2008 | WO2008062206A3 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus |
07/10/2008 | WO2008029294A3 Method of producing anthracycline derivatives |
07/10/2008 | WO2008010921A3 Modulators of pharmacokinetic properties of therapeutics |
07/10/2008 | WO2007138047A3 Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
07/10/2008 | WO2007133865A3 Hcv/hiv inhibitors an their uses |
07/10/2008 | WO2007000342A8 Immunogenic composition |
07/10/2008 | WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling |
07/10/2008 | US20080167464 Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
07/10/2008 | US20080167444 Abc Transporter Inhibitor |
07/10/2008 | US20080167373 intermediate for side chain functionalization of fimbrolides (halogenated 3-alkyl-5-methylene-2(5H)-furanones); 4-Bromo-5(bromomethylene)-3-(1-bromoethyl)-2(5H)-furanone from N-bromosuccinimide the 3-ethylfuranone |
07/10/2008 | US20080167362 Time-release tablets or capsules also containing an opoid or analgesic; cyclooxygenase-2 inhibitors |
07/10/2008 | US20080167325 Preparation of a valacyclovir composition that does not include wet granulation, e.g., dry granulation and compressing a powder blend to form tablets |
07/10/2008 | US20080167318 Pharmaceutically active pyrrolidine derivatives |
07/10/2008 | US20080167314 Condensed Imidazole Compound And Use Thereof |
07/10/2008 | US20080167312 Preparation and utility of substituted allylamines |
07/10/2008 | US20080167302 Peptide Deformylase Inhibitors |
07/10/2008 | US20080167296 Aids therapy; viricides |
07/10/2008 | US20080167285 Bactericides; bacteriostats; therapy for bacteria infections |
07/10/2008 | US20080167273 Therapy against tetracycline-resistant organisms; bactericides; bacteriostats; escherichia; straphococcus; enterococcus; anticancer agents; antidiabetic agents |
07/10/2008 | US20080167257 Therapy of acroparaesthsia, allergic (psoric) conditions, allergic reactions, alopecia, amnesia, anaphrodisia, angina, arthritis, asthenopia, biliary sycosis, burns, cancerous conditions, such as colon cancer, malignant melanoma and malignant nasal polyps, carpal tunnel syndrome, colds, conjunctivitis |
07/10/2008 | US20080167233 treating papilloma by administering biologically a complex of alpha-lactalbumin in the apo folded state and a cis C18 unsaturated fatty acid cofactor which stabilizes the complex in a biologically active form |
07/10/2008 | US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies |
07/10/2008 | US20080167224 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases |
07/10/2008 | US20080167199 Multimerization of HIV-1 vif protein as a therapeutic target |
07/10/2008 | US20080166800 Method and medicament for inhibiting the expression of a given gene |
07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
07/10/2008 | US20080166765 Fungal cell wall synthesis gene |
07/10/2008 | US20080166439 Chinese traditional medicine composition for treatment of avian influenza, method for preparation and application thereof |
07/10/2008 | US20080166435 Composition and methods of use of an immunomodulator |
07/10/2008 | US20080166430 Antimicrobial formulation comprising lactic acid and acidic calcium sulfate with caprylic acid, sodium benzoate, butyric acid and/or chlorine dioxide. |
07/10/2008 | US20080166426 Including sangre de grado isolate from lechleri croton tree; staphylococci, streptococci and/or enterococcus faecalis infections; overcoming antibiotic resistance |
07/10/2008 | US20080166413 Topical pharmaceutical formulations and methods of treatment |
07/10/2008 | US20080166398 Antifungal Compositions |
07/10/2008 | US20080166393 For contact lenses; sealed pouches |
07/10/2008 | US20080166388 Which cause little lysis of human red blood cells at concentrations that kill Candida albicans; kits; stent, valve, pacemaker, defibrillator, artificial joint, prosthesis, neurostimulator, ventricular assist device, congestive heart failure device, indwelling catheter, insulin pump, incontinence device |
07/10/2008 | US20080166373 METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-alpha NUCLEIC ACIDS |
07/10/2008 | US20080166372 Live Attenuated Rotavirus Vaccine for Oral Administration |
07/10/2008 | US20080166363 Improved targetting |
07/10/2008 | US20080166355 Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon |
07/10/2008 | US20080166353 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders |
07/10/2008 | US20080166304 Contacting the microorganism with a phenothiazinium and a microbial MDR inhibitor and irradiating the phenothiazinium producing a phototoxic species that inactivates the microorganism |
07/10/2008 | DE102007001370A1 RNA-kodierte Antikörper RNA-encoded antibody |
07/10/2008 | DE102007001198A1 Reducing anomer of a spectinomycin, useful in veterinary medical antibiotic, comprises providing a substance comprising spectinomycin, spectinomycin-salts, spectinomycin salt-hydrate and contaminating anomer and autoclaving the substance |
07/10/2008 | CA2674185A1 Hiv inhibiting 5,6-substituted pyrimidines |
07/10/2008 | CA2674178A1 Hiv inhibiting 6-substituted pyrimidines |
07/10/2008 | CA2673976A1 Gel composition for treating mycosis |
07/10/2008 | CA2673870A1 Compositions and methods for the treatment of infections and tumors |
07/10/2008 | CA2673809A1 Thioxanthene derivates useful to treat infectious diseases |
07/10/2008 | CA2673752A1 Compositions and methods for stimulating an immune response |
07/10/2008 | CA2673506A1 Antibacterial compounds and processes for its production |
07/10/2008 | CA2673249A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
07/10/2008 | CA2672538A1 Pharmaceutical compositions of alkyl gallates |
07/09/2008 | EP1942187A1 Cytokine protein family |
07/09/2008 | EP1942181A1 Bacterium causing poultry disease and vaccine derived thereof |
07/09/2008 | EP1942108A1 Compound containing basic group and use thereof |
07/09/2008 | EP1941888A1 Method of inhibiting the proliferation and migration of helicobacter pylori |
07/09/2008 | EP1941885A2 Homopiperazine compounds that inhibit ribosomal frameshifting by binding to rna pseudoknot structure of sars coronavirus |
07/09/2008 | EP1941880A1 Lotion preparation containing pyridonecarboxylic acid derivative |
07/09/2008 | EP1941875A1 Use of lipoxin analogs to promote cell defense against gram-negative infections |
07/09/2008 | EP1941873A1 Metallo-beta-lactamase inhibitor |
07/09/2008 | EP1940828A2 Heterocyclic aspartyl protease inhibitors |
07/09/2008 | EP1940787A1 Novel ido inhibitors and methods of use thereof |
07/09/2008 | EP1940786A1 Biphenyl derivatives and their use in treating hepatitis c |
07/09/2008 | EP1940781A1 Phenyl-acetamide nnrt inhibitors |
07/09/2008 | EP1940430A2 Listeria-induced immunorecruitment and activation, and methods of use thereof |
07/09/2008 | EP1940421A1 Use of amine-borane compounds as anti-microbial agents |